Literature DB >> 25262954

Comparison of the quantitative CT imaging biomarkers of idiopathic pulmonary fibrosis at baseline and early change with an interval of 7 months.

Hyun J Kim1, Matthew S Brown2, Daniel Chong2, David W Gjertson3, Peiyun Lu2, Hak J Kim4, Heidi Coy2, Jonathan G Goldin2.   

Abstract

RATIONALE AND
OBJECTIVES: Median survival of patients with idiopathic pulmonary fibrosis (IPF) is 2-5 years. Sensitive imaging metrics can play a role in detecting early changes in therapeutic development. The aim of the present study was to compare known computed tomography (CT) histogram kurtosis and a classifier-based quantitative score to assess baseline severity and change over time in patients with IPF.
MATERIALS AND METHODS: A total of 57 patients with at least baseline and paired follow-up scans were selected from an imaging database of standardized CT scans obtained from patients with IPF. CT histogram measurement of kurtosis and quantitative lung fibrosis (QLF) and quantitative interstitial lung disease (QILD) scores from a classification algorithm were calculated. Spearman rank correlations were used to assess associations between baseline severity and changes for all CT-derived measures compared to forced vital capacity (FVC) and carbon monoxide diffusion capacity (DLCO) (percent predicted).
RESULTS: At baseline, mean (±SD) of kurtosis was 2.43 (±1.83). Mean (±SD) values of QLF and QILD scores were 20.7% (±13.4) and 43.3% (±20.0), respectively. All baseline histogram indices and QLF and QILD scores were correlated well with baseline FVC and DLCO. When assessing associations with changes in FVC and DLCO over time, only QLF score was statistically significant (ρ = -0.57; P < .0001 for FVC and ρ = -0.34; P = .025 for DLCO), whereas kurtosis was not.
CONCLUSIONS: Classifier-model-derived scores (QLF and QILD), based on a set of texture features, are associated with baseline disease extent and are also a sensitive measure of change over time. A QLF score can be used for measuring the extent of disease severity and longitudinal changes.
Copyright © 2015 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CAD; ILD; IPF; Texture; imaging biomarkers; quantitative lung fibrosis

Mesh:

Year:  2014        PMID: 25262954     DOI: 10.1016/j.acra.2014.08.004

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  33 in total

1.  Quantitative computed tomography detects interstitial lung diseases proven by biopsy.

Authors:  Alarico Ariani; Andrea Imperatori; Massimo Castiglioni; Elisa Daffrè; Marina Aiello; Giuseppina Bertorelli; Alfredo Chetta; Lorenzo Dominioni; Nicola Rotolo
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis.

Authors:  Susan K Mathai; Stephen Humphries; Jonathan A Kropski; Timothy S Blackwell; Julia Powers; Avram D Walts; Cheryl Markin; Julia Woodward; Jonathan H Chung; Kevin K Brown; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha Fingerlin; Ivana V Yang; David A Lynch; David A Schwartz
Journal:  Thorax       Date:  2019-09-26       Impact factor: 9.139

3.  High throughput image labeling on chest computed tomography by deep learning.

Authors:  Xiaoyong Wang; Pangyu Teng; Ashley Ontiveros; Jonathan G Goldin; Matthew S Brown
Journal:  J Med Imaging (Bellingham)       Date:  2020-03-20

4.  The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers.

Authors:  Samuel Y Ash; Rola Harmouche; James C Ross; Alejandro A Diaz; Gary M Hunninghake; Rachel K Putman; Jorge Onieva; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Acad Radiol       Date:  2016-12-15       Impact factor: 3.173

Review 5.  Lung densitometry: why, how and when.

Authors:  Mario Mascalchi; Gianna Camiciottoli; Stefano Diciotti
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

6.  Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes.

Authors:  Margaret L Salisbury; David A Lynch; Edwin J R van Beek; Ella A Kazerooni; Junfeng Guo; Meng Xia; Susan Murray; Kevin J Anstrom; Eric Yow; Fernando J Martinez; Eric A Hoffman; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2017-04-01       Impact factor: 21.405

7.  Visual vs Fully Automatic Histogram-Based Assessment of Idiopathic Pulmonary Fibrosis (IPF) Progression Using Sequential Multidetector Computed Tomography (MDCT).

Authors:  Davide Colombi; Julien Dinkel; Oliver Weinheimer; Berenike Obermayer; Teodora Buzan; Diana Nabers; Claudia Bauer; Ute Oltmanns; Karin Palmowski; Felix Herth; Hans Ulrich Kauczor; Nicola Sverzellati; Michael Kreuter; Claus Peter Heussel
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

8.  Quantitative CT characterization of pediatric lung development using routine clinical imaging.

Authors:  Jill M Stein; Laura L Walkup; Alan S Brody; Robert J Fleck; Jason C Woods
Journal:  Pediatr Radiol       Date:  2016-08-30

9.  Using hyperpolarized 129Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis.

Authors:  Jennifer M Wang; Scott H Robertson; Ziyi Wang; Mu He; Rohan S Virgincar; Geoffry M Schrank; Rose Marie Smigla; Thomas G O'Riordan; John Sundy; Lukas Ebner; Craig R Rackley; Page McAdams; Bastiaan Driehuys
Journal:  Thorax       Date:  2017-08-31       Impact factor: 9.139

10.  Prediction of idiopathic pulmonary fibrosis progression using early quantitative changes on CT imaging for a short term of clinical 18-24-month follow-ups.

Authors:  Grace Hyun J Kim; Stephan S Weigt; John A Belperio; Matthew S Brown; Yu Shi; Joshua H Lai; Jonathan G Goldin
Journal:  Eur Radiol       Date:  2019-08-26       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.